Advertisement
Screener

BOSTON SCIENTIFIC CORPORATION (BSX) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum

3.0 / 5 stars · 73/120 Roast Me

BOSTON SCIENTIFIC CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum

BOSTON SCIENTIFIC CORPORATION (BSX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 2.61% for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-19.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2019-02-19

  • BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2018 was 2.61%, a 28.57% increase from fiscal 2017.
  • BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2017 was 2.03%, a 78.07% increase from fiscal 2016.
  • BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2016 was 1.14%, a 23.49% decline from fiscal 2015.
  • BOSTON SCIENTIFIC CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2015 was 1.49%, a 11.83% decline from fiscal 2014.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month
2018-12-312.61%
10-K · filed 2019-02-19
2017-12-312.03%
10-K · filed 2019-02-19
2016-12-311.14%
10-K · filed 2019-02-19
2015-12-311.49%
10-K · filed 2018-02-20
2014-12-311.69%
10-K · filed 2017-02-23
2013-12-310.89%
10-K · filed 2016-02-24
2012-12-310.95%
10-K · filed 2015-02-25
2011-12-311.16%
10-K · filed 2014-02-26
2010-12-311.52%
8-K · filed 2013-05-29
2009-12-311.80%
10-K · filed 2012-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
BECTON DICKINSON & CO (BDX)United States$48.834B43.79
3M CO (MMM)United States$86.404B27.87
DEXCOM INC (DXCM)United States$33.004B25.42
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
STRYKER CORP (SYK)United States$103.511B32.39
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12